Vertex Pharmaceuticals
$180.189876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$180.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$4.06 (-2.20%) Today
$0.00 (0.00%) As of 4:21 PM EDT after-hours
Why Robinhood?
You can buy or sell VRTX and other stocks, options, ETFs, and crypto commission-free!
About VRTX
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. Read More The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
Employees
2,500
Headquarters
Boston, Massachusetts
Founded
1989
Market Cap
46.31B
Price-Earnings Ratio
21.12
Dividend Yield
0.00
Average Volume
1.08M
High Today
$186.78
Low Today
$179.24
Open Price
$184.36
Volume
1.20M
52 Week High
$195.81
52 Week Low
$151.80
Collections
VRTX News
Price Paid on Robinhood
11% Higher
Right Now
52 Week Low
$144.07
Average Price Paid
$162.97
52 Week High
$195.81
Analyst Ratings
71%
of 24 ratings
Buy
71%
Hold
29%
Sell
0%
VRTX Earnings
$0.53
$0.79
$1.04
$1.30
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Oct 30, After Hours
